相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Automatic segmentation methods for liver and hepatic vessels from CT and MRI volumes, applied to the Couinaud scheme
Marie-Ange Lebre et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2019)
Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk score
Elisabeth Gasser et al.
PLOS ONE (2019)
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy
Marco Ravanelli et al.
RADIOLOGIA MEDICA (2019)
Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study
Sirui Fu et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)
Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method
Jin Cheng et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases
Boris Galjart et al.
ANGIOGENESIS (2019)
Radiomics Signature on Magnetic Resonance Imaging: Association with Disease-Free Survival in Patients with Invasive Breast Cancer
Hyunjin Park et al.
CLINICAL CANCER RESEARCH (2018)
Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group
Kaitlyn K. H. Goey et al.
EUROPEAN JOURNAL OF CANCER (2018)
Growth patterns of colorectal cancer liver metastases and their impact on prognosis: a systematic review
Carlos Fernandez Moro et al.
BMJ OPEN GASTROENTEROLOGY (2018)
Vascularization of colorectal carcinoma liver metastasis: insight into stratification of patients for anti-angiogenic therapies
Anthoula Lazaris et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2018)
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumab
Patrick Grossmann et al.
NEURO-ONCOLOGY (2017)
Associations between Tumor Vascularity, Vascular Endothelial Growth Factor Expression and PET/MRI Radiomic Signatures in Primary Clear-Cell-Renal-Cell-Carcinoma: Proof-of-Concept Study
Qingbo Yin et al.
SCIENTIFIC REPORTS (2017)
International consensus guidelines for scoring the histopathological growth patterns of liver metastasis
Pieter-Jan van Dam et al.
BRITISH JOURNAL OF CANCER (2017)
T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower- grade Gliomas: A TCGA/TCIA Project
Sohil H. Patel et al.
CLINICAL CANCER RESEARCH (2017)
Somatic Mutations Drive Distinct Imaging Phenotypes in Lung Cancer
Emmanuel Rios Velazquez et al.
CANCER RESEARCH (2017)
Promises and challenges for the implementation of computational medical imaging (radiomics) in oncology
E. J. Limkin et al.
ANNALS OF ONCOLOGY (2017)
Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response
Philipp Kickingereder et al.
CLINICAL CANCER RESEARCH (2016)
Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases
Sophia Frentzas et al.
NATURE MEDICINE (2016)
Radiomics Signature: A Potential Biomarker for the Prediction of Disease-Free Survival in Early-Stage (I or II) Non-Small Cell Lung Cancer
Yanqi Huang et al.
RADIOLOGY (2016)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Update on the Role of Imaging in Management of Metastatic Colorectal Cancer
Sree Harsha Tirumani et al.
RADIOGRAPHICS (2014)
Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability
Ralph T. H. Leijenaar et al.
ACTA ONCOLOGICA (2013)
The histological growth pattern of colorectal cancer liver metastases has prognostic value
Gert G. Van den Eynden et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Do Imaging Biomarkers Relate to Outcome in Patients Treated with VEGF Inhibitors?
James P. B. O'Connor et al.
CLINICAL CANCER RESEARCH (2012)
Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies
James P. B. O'Connor et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Histopathological Growth Pattern, Proteolysis and Angiogenesis in Chemonaive Patients Resected forMultiple Colorectal LiverMetastases
Rikke Lovendahl Eefsen et al.
JOURNAL OF ONCOLOGY (2012)
DCE-MRI biomarkers of tumour heterogeneity predict CRC liver metastasis shrinkage following bevacizumab and FOLFOX-6
J. P. B. O'Connor et al.
BRITISH JOURNAL OF CANCER (2011)
Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia
PB Vermeulen et al.
JOURNAL OF PATHOLOGY (2001)
Computed tomographic features of colorectal carcinoma liver metastases predict posthepatectomy patient survival
S Nagakura et al.
DISEASES OF THE COLON & RECTUM (2001)
Perilesional enhancement of hepatic metastases: Correlation between MR imaging and histopathologic findings - Initial observations
RC Semelka et al.
RADIOLOGY (2000)